Gordon Harris

Gordon Harris, Co-founder and Chief Science Officer at Yunu, leverages his expertise in medical imaging to discuss revolutionary advancements in clinical trials. He explores how technology can streamline processes, enhance global site connectivity, and improve patient access to trials. The conversation highlights the importance of interoperability and innovative platforms in addressing industry challenges. Harris also emphasizes the concept of 'naive optimism' in driving positive change and fostering creative collaboration in clinical trial innovation.